11.07.2015 Views

Prescribed Drugs Provider Manual - Iowa Department of Human ...

Prescribed Drugs Provider Manual - Iowa Department of Human ...

Prescribed Drugs Provider Manual - Iowa Department of Human ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Iowa</strong><strong>Department</strong><strong>of</strong> <strong>Human</strong>Services<strong>Provider</strong> and Chapter<strong>Prescribed</strong> <strong>Drugs</strong>Chapter III. <strong>Provider</strong>-Specific PoliciesPage86DateAugust 1, 2013Use form 470-4850, Request for Prior Authorization: ThrombopoietinReceptor Agonists, to request prior authorization. Click here to see a sample<strong>of</strong> the form.71. Topical RetinoidsPrior authorization is required for all prescription topical retinoid products.Payment for prescription topical retinoid products will be considered underthe following conditions:♦ Patients with a diagnosis <strong>of</strong> skin cancer, lamellar ichthyosis, or Darier’sdisease will receive automatic approval for lifetime use <strong>of</strong> topical retinoidproducts.♦ Payment will be authorized when the patient has had previous trial andtherapy failure with:• A preferred over-the-counter benzoyl peroxide product, and• Two preferred topical or oral antibiotics for the treatment <strong>of</strong> mild tomoderate acne (noninflammatory and inflammatory) or drug-inducedacne.EXCEPTION: Trials and therapy failure are not required for patientspresenting with a preponderance <strong>of</strong> comedonal acne.♦ Payment for nonpreferred topical retinoid products will be authorized onlyfor cases in which there is documentation <strong>of</strong> previous trial and therapyfailure with a preferred agent.♦ Requests for nonpreferred combination products wil be considered onlyafter documentation <strong>of</strong> separate trials and therapy failures with theindividual ingredients.♦ Trial and therapy failure with a preferred topical antipsoriatic agent willnot be required for tazorac for a psoriasis diagnosis.The required trials may be overridden when documented evidence is providedthat the use <strong>of</strong> these agents would be medically contraindicated.Use form 470-4114, Request for Prior Authorization: Topical Retinoids forAcne, to request prior authorization. Click here to see a sample <strong>of</strong> the form.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!